JPH029384A - Production of l-glutamic acid by fermentation process - Google Patents
Production of l-glutamic acid by fermentation processInfo
- Publication number
- JPH029384A JPH029384A JP15975088A JP15975088A JPH029384A JP H029384 A JPH029384 A JP H029384A JP 15975088 A JP15975088 A JP 15975088A JP 15975088 A JP15975088 A JP 15975088A JP H029384 A JPH029384 A JP H029384A
- Authority
- JP
- Japan
- Prior art keywords
- glutamic acid
- culture
- gramicidin
- acid
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 title claims abstract description 57
- 229960002989 glutamic acid Drugs 0.000 title claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 238000000855 fermentation Methods 0.000 title claims description 9
- 230000004151 fermentation Effects 0.000 title claims description 9
- 108010026389 Gramicidin Proteins 0.000 claims abstract description 16
- 229960004905 gramicidin Drugs 0.000 claims abstract description 13
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 claims abstract description 13
- 244000005700 microbiome Species 0.000 claims abstract description 7
- 241000186216 Corynebacterium Species 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 10
- 241000186146 Brevibacterium Species 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 abstract description 7
- 239000001963 growth medium Substances 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 241000186312 Brevibacterium sp. Species 0.000 abstract 2
- 150000008539 L-glutamic acids Chemical class 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 235000013379 molasses Nutrition 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000186226 Corynebacterium glutamicum Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- MNULEGDCPYONBU-WMBHJXFZSA-N (1r,4s,5e,5'r,6'r,7e,10s,11r,12s,14r,15s,16s,18r,19s,20r,21e,25s,26r,27s,29s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-[(2s)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trio Polymers O([C@@H]1CC[C@@H](/C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]([C@H]2C)[C@H]1C)CC)[C@]12CC[C@@H](C)[C@@H](C[C@H](C)O)O1 MNULEGDCPYONBU-WMBHJXFZSA-N 0.000 description 2
- MNULEGDCPYONBU-DJRUDOHVSA-N (1s,4r,5z,5'r,6'r,7e,10s,11r,12s,14r,15s,18r,19r,20s,21e,26r,27s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-(2-hydroxypropyl)-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers O([C@H]1CC[C@H](\C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)C(C)C(=O)[C@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)OC([C@H]2C)C1C)CC)[C@]12CC[C@@H](C)[C@@H](CC(C)O)O1 MNULEGDCPYONBU-DJRUDOHVSA-N 0.000 description 2
- MNULEGDCPYONBU-YNZHUHFTSA-N (4Z,18Z,20Z)-22-ethyl-7,11,14,15-tetrahydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione Polymers CC1C(C2C)OC(=O)\C=C/C(C)C(O)C(C)C(=O)C(C)C(O)C(C)C(=O)C(C)(O)C(O)C(C)C\C=C/C=C\C(CC)CCC2OC21CCC(C)C(CC(C)O)O2 MNULEGDCPYONBU-YNZHUHFTSA-N 0.000 description 2
- MNULEGDCPYONBU-VVXVDZGXSA-N (5e,5'r,7e,10s,11r,12s,14s,15r,16r,18r,19s,20r,21e,26r,29s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-[(2s)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers C([C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)OC([C@H]1C)[C@H]2C)\C=C\C=C\C(CC)CCC2OC21CC[C@@H](C)C(C[C@H](C)O)O2 MNULEGDCPYONBU-VVXVDZGXSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- MNULEGDCPYONBU-UHFFFAOYSA-N 4-ethyl-11,12,15,19-tetrahydroxy-6'-(2-hydroxypropyl)-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers CC1C(C2C)OC(=O)C=CC(C)C(O)C(C)C(=O)C(C)C(O)C(C)C(=O)C(C)(O)C(O)C(C)CC=CC=CC(CC)CCC2OC21CCC(C)C(CC(C)O)O2 MNULEGDCPYONBU-UHFFFAOYSA-N 0.000 description 2
- UIFFUZWRFRDZJC-UHFFFAOYSA-N Antimycin A1 Natural products CC1OC(=O)C(CCCCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-UHFFFAOYSA-N 0.000 description 2
- NQWZLRAORXLWDN-UHFFFAOYSA-N Antimycin-A Natural products CCCCCCC(=O)OC1C(C)OC(=O)C(NC(=O)c2ccc(NC=O)cc2O)C(C)OC(=O)C1CCCC NQWZLRAORXLWDN-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- UIFFUZWRFRDZJC-SBOOETFBSA-N antimycin A Chemical compound C[C@H]1OC(=O)[C@H](CCCCCC)[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@H]1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-SBOOETFBSA-N 0.000 description 2
- PVEVXUMVNWSNIG-UHFFFAOYSA-N antimycin A3 Natural products CC1OC(=O)C(CCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O PVEVXUMVNWSNIG-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- -1 nlubitol Chemical class 0.000 description 2
- 229930191479 oligomycin Natural products 0.000 description 2
- MNULEGDCPYONBU-AWJDAWNUSA-N oligomycin A Polymers O([C@H]1CC[C@H](/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]([C@@H]2C)[C@@H]1C)CC)[C@@]12CC[C@H](C)[C@H](C[C@@H](C)O)O1 MNULEGDCPYONBU-AWJDAWNUSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- WCLKSQYCWXZMGX-UHFFFAOYSA-N 1,2,3,4-tetrabromo-5,6-dimethoxybenzene Chemical compound COC1=C(Br)C(Br)=C(Br)C(Br)=C1OC WCLKSQYCWXZMGX-UHFFFAOYSA-N 0.000 description 1
- SRKQWNFPTBNUKE-UHFFFAOYSA-N 1-methyl-1,2-dinitroguanidine Chemical compound [O-][N+](=O)N(C)\C(N)=N/[N+]([O-])=O SRKQWNFPTBNUKE-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 239000004154 Calcium bromate Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 108010067973 Valinomycin Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000019397 calcium bromate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- NDAYQJDHGXTBJL-MWWSRJDJSA-N chembl557217 Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 NDAYQJDHGXTBJL-MWWSRJDJSA-N 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- FCFNRCROJUBPLU-UHFFFAOYSA-N compound M126 Natural products CC(C)C1NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC1=O FCFNRCROJUBPLU-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- IUAYMJGZBVDSGL-XNNAEKOYSA-N gramicidin S Chemical compound C([C@@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1)C(C)C)=O)CC(C)C)C(C)C)C1=CC=CC=C1 IUAYMJGZBVDSGL-XNNAEKOYSA-N 0.000 description 1
- 229950009774 gramicidin s Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- FCFNRCROJUBPLU-DNDCDFAISA-N valinomycin Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O FCFNRCROJUBPLU-DNDCDFAISA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は発酵法によるし一グルタミン酸の製造法に関す
る。その目的は、食品添加物等として利用される重要な
アミノ酸であるL−グルタミン酸を工業的に安価に製造
することにある。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a method for producing monoglutamic acid by fermentation. The purpose is to industrially produce L-glutamic acid, which is an important amino acid used as a food additive, at low cost.
従来の技術
従来、発酵法によるし一グルタミン酸の製造法に関して
は、コリネバクテリウム属、ブレビバクテリウム属の野
生株あるいは、種々の物質を生育に要求するか又は種々
の物質に耐性を有する変異株を用いる方法が知られてい
る。また、エネルギー代謝阻害を示す抗生物質またはユ
ビキノンの生合成の前駆体に耐性を示し、L−グルタミ
ン酸生産能を有する微生物を用いる方法(特開昭59−
15.4995)が知られている。Conventional technology Conventionally, for the production of monoglutamic acid by fermentation, wild strains of the genus Corynebacterium and Brevibacterium or mutant strains that require various substances for growth or are resistant to various substances have been used. A method using . In addition, a method using microorganisms that are resistant to antibiotics that inhibit energy metabolism or precursors of ubiquinone biosynthesis and that has the ability to produce L-glutamic acid (Japanese Patent Laid-Open No. 59-1979-1)
15.4995) is known.
発明が解決しようとする課題
食品添加物等として有用なし一グルタミン酸の安価な製
造法が求められている。Problems to be Solved by the Invention There is a need for an inexpensive method for producing monoglutamic acid, which is not useful as a food additive or the like.
、′J!題を解決するための手段
本発明社らは、L−グルタミン酸を高収率で得るために
より(衾れたL−グルタミン酸生7帝菌の研究を行った
。その結果、エネルギー代謝阻害剤として知られている
各種抗生物質の耐性株の中で、特にグラミシジンに耐性
を有する変異株が高収率で、L−グルタミン酸を生産す
ることを見出し本発明を完成させた。,'J! In order to obtain L-glutamic acid in high yield, the present inventors conducted research on seven bacteria that produce L-glutamic acid. Among the various antibiotic-resistant strains that have been identified, the present invention was completed by discovering that a mutant strain that is particularly resistant to gramicidin produces L-glutamic acid at a high yield.
以下、本発明を具体的に説明する。The present invention will be explained in detail below.
本発明は、コリネバクテリウム属またはプレビバクテリ
ウム属に属し、グラミシジンに耐性を有し、かつL−グ
ルタミン酸生産能を有する微生物を培地に培養し、培養
物中にL−グルタミン酸を生成蓄積せしめ、該培養物よ
りL−グルタミン酸を採取することを特徴とする発酵法
によるL−グルタミン酸の製造法を提供する。The present invention involves culturing a microorganism belonging to the genus Corynebacterium or the genus Previbacterium, resistant to gramicidin, and capable of producing L-glutamic acid in a medium, producing and accumulating L-glutamic acid in the culture, Provided is a method for producing L-glutamic acid by a fermentation method, which is characterized in that L-glutamic acid is collected from the culture.
本発明に使用する微生物の例としては、コリネバクテリ
ウム属またはブレビバクテリウム属に属し、グラミシジ
ン耐性を有し、かつL−グルタミン酸生産能を有する微
生物であればいずれも用いることができる。As an example of the microorganism used in the present invention, any microorganism that belongs to the genus Corynebacterium or Brevibacterium, has resistance to gramicidin, and has L-glutamic acid producing ability can be used.
本変異株は、コリネバクテリウム属またはブレビバクテ
リウム属のし一グルタミン酸生産性細菌から誘導するこ
とにより、あるいは、上記性質を有する菌にL−グルタ
ミン酸生産性を付与することによって得られる。This mutant strain can be obtained by deriving from a monoglutamic acid-producing bacterium of the genus Corynebacterium or Brevibacterium, or by imparting L-glutamic acid productivity to a bacterium having the above properties.
例えば、L−グルタミン酸生産菌コリネバクテリウム・
グルタミクムATCC−13032をX線、紫外線、コ
バルト等の照射あるいは薬剤、例えば、N−メチル−N
′−二トローN−二トロングアニジンに接触せし袷る等
の通常の変異誘導方法が適宜適用できる。For example, L-glutamic acid producing bacteria Corynebacterium
Glutamicum ATCC-13032 is irradiated with X-rays, ultraviolet rays, cobalt, etc., or treated with drugs such as N-methyl-N.
Conventional mutagenesis methods such as contacting with '-nitro-N-nitro-longanidine can be applied as appropriate.
変異処理した菌体から変異株を分離する方法は、親株が
生育できない量のグラミシジンを含む固体培地中に生育
できるような菌株を採取するこきにより行われる。A method for isolating a mutant strain from cells subjected to mutation treatment is to collect a strain that can grow in a solid medium containing an amount of gramicidin in which the parent strain cannot grow.
以下に変異株の取得方法の具体例を示す。A specific example of how to obtain a mutant strain is shown below.
コリネバクテリウム・グルタミクムATCC13032
にN−メチル−N′−二トローN−二トロングアニジン
による通常の変異処理(200mg/j’、30℃、3
0分間)を行った後、lO鱈/m Iのグラミシジンを
含む最小培地〔グルコース10g/β、塩化アンモニウ
ム4g/j!、KH2PO。Corynebacterium glutamicum ATCC13032
was subjected to the usual mutation treatment with N-methyl-N'-nitro-N-nitroguanidine (200 mg/j', 30°C, 3
0 min), followed by minimal medium containing lO cod/m I of gramicidin [glucose 10 g/β, ammonium chloride 4 g/j! , KH2PO.
Ig#、に2HPO43g/It、Mg5O,・7H2
00,01g/j!、Fe50.・7H,OO,01g
/12.MnSO4’4HzOOlo 1 g/1.尿
素2g/j!、ビオチン50■/I!、寒天20 g/
It。Ig#, 2HPO43g/It, Mg5O, 7H2
00,01g/j! , Fe50.・7H,OO,01g
/12. MnSO4'4HzOOlo 1 g/1. Urea 2g/j! , Biotin 50■/I! , agar 20 g/
It.
p H7,2)に塗布する。30℃で2〜6日培養し、
生育してくるグラミシジン耐性のコロニーを取得する。Apply at pH 7.2). Cultured at 30°C for 2 to 6 days,
Obtain gramicidin-resistant colonies that grow.
グラミシジンはシグマ社製(グラミシジンDまたはグラ
ミシジンNFともよばれる)を使用する。グラミシジン
の耐性株50株を釣菌し、親株よりL−グルタミン酸生
産能が向上した菌株を分離する。代表的な菌株として、
コリネバクテリウム・グルタミクムH−7110があげ
られる。Gramicidin manufactured by Sigma (also called Gramicidin D or Gramicidin NF) is used. Fifty strains resistant to gramicidin were harvested, and strains with improved L-glutamic acid production ability than the parent strain were isolated. As a representative strain,
Examples include Corynebacterium glutamicum H-7110.
本菌株1よ、昭和63年5月11日付で、工業技術院微
生物工業技術研究所にFERM BP−1876として
寄託されている。This strain 1 was deposited as FERM BP-1876 with the Institute of Microbial Technology, Agency of Industrial Science and Technology on May 11, 1986.
本発明で用いる培地としては、炭素源、窒素源。The culture medium used in the present invention includes a carbon source and a nitrogen source.
無機物、その他使用菌株の必要とする微1の栄養素を捏
良く含有するものであれば合成培地および天然培地のい
ずれも使用できる。Both synthetic and natural media can be used as long as they contain inorganic substances and other micronutrients required by the strain used.
すなわち炭素源としてはグルコース、フラクトース、シ
ークロース、マルトース、マンノース。In other words, carbon sources include glucose, fructose, sucrose, maltose, and mannose.
ンルビトール等の炭水化物、糖アルコール、グリセロー
ル、′il粉、澱粉加水分解物、糖蜜などが使用でき、
また酢酸、ピルビン酸、乳酸、フマール酸、グルコン酸
等の有機酸、およびアスパラギン酸などのアミノ酸類、
あるいはエタノールなどの低級アルコールも使用できる
。Carbohydrates such as nlubitol, sugar alcohols, glycerol, 'il powder, starch hydrolysates, molasses, etc. can be used.
In addition, organic acids such as acetic acid, pyruvic acid, lactic acid, fumaric acid, and gluconic acid, and amino acids such as aspartic acid,
Alternatively, lower alcohols such as ethanol can also be used.
窒素源としては、アンモニア、塩化アンモニウム、硫酸
アンモニウム、炭酸アンモニウム、リン酸アンモニウム
、酢酸アンモニウムなどの各種無機および有機アンモニ
ウム塩類、あるいはアスパラギン酸などのアミノ酸類、
尿素および窒素含有物質、例えばペプトン、肉エキス、
コーン・ステイープ・リカー、カゼイン加水分解物、大
豆の加水分解物などの種々のものが使用できる。Nitrogen sources include various inorganic and organic ammonium salts such as ammonia, ammonium chloride, ammonium sulfate, ammonium carbonate, ammonium phosphate, ammonium acetate, or amino acids such as aspartic acid,
urea and nitrogen-containing substances such as peptone, meat extracts,
Various products can be used, such as corn steep liquor, casein hydrolyzate, and soybean hydrolyzate.
無機物としてはリン酸二水素カリウム、リン酸水素二カ
リウム、硫酸マグネシウム、塩化す) IJウム、硫酸
第一鉄、硫酸マンガンおよび炭酸カルシウム等が用いら
れる。As the inorganic substances, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, calcium carbonate, etc. are used.
さらに、必要に応じてビオチン、ニコチンアミド、パン
トテン酸、サイアミン等の微生物の生育に必要なビタミ
ン類も使用されるが、これらの物質は前記のような他の
培地組成に伴って培地に供されれば、特に加えなくても
よい。Furthermore, vitamins necessary for the growth of microorganisms, such as biotin, nicotinamide, pantothenic acid, and thiamine, are also used as necessary, but these substances are provided in the medium along with the other medium compositions mentioned above. If so, there is no need to add it.
培養は振盪培養または深部通気攪拌培養などの好気的条
件下で行う。培養は温度20〜40℃で、pH3〜9の
範囲で、好ましくは中性付近に保持する。培地のpH調
整は臭酸カルシウム、有機または無機の酸、アルカリ溶
液、アンモニア、pH緩所液などによって行う。培養時
間は通常1〜4日間で培養液中にL−グルタミン酸が生
成M積する。Cultivation is performed under aerobic conditions such as shaking culture or deep aeration agitation culture. The culture is maintained at a temperature of 20 to 40°C and a pH in the range of 3 to 9, preferably around neutrality. The pH of the culture medium is adjusted using calcium bromate, an organic or inorganic acid, an alkaline solution, ammonia, a pH reducing solution, or the like. The culture time is usually 1 to 4 days, and L-glutamic acid is produced in the culture solution.
またL−グルタミン酸を蓄晴させるため、従来知られて
いるように、ビオチン咄を低く抑えたり、ビオチン含有
1の高い培地の場合には界面活性剤。In addition, in order to accumulate L-glutamic acid, as is conventionally known, biotin powder should be kept low, or in the case of a medium with a high biotin content, a surfactant should be used.
ペニシリン等を添加してもよい。Penicillin etc. may be added.
培ff終了後、培養液よりL−グルタミン酸を採取する
には、培養液より菌体などの固形分を除去し、公知のイ
オン交換処理法、a縮性、吸着法。After culturing, to collect L-glutamic acid from the culture solution, solids such as bacterial cells are removed from the culture solution, and a known ion exchange treatment method, acondensation method, and adsorption method are used.
塩析法などを併用することにより、培養液からLグルタ
ミン酸を回収することができる。L-glutamic acid can be recovered from the culture solution by using a salting-out method or the like.
以下、実施例をあげて本発明を具体的に説明する。Hereinafter, the present invention will be specifically explained with reference to Examples.
実施例1゜
種菌としてコリネバクテリウム・グルタミクムH−71
10(FERM BP−1876)株を用いた。H−
7110株をグルコース40g/I!。Example 1 Corynebacterium glutamicum H-71 as inoculum
10 (FERM BP-1876) strain was used. H-
7110 strain with glucose 40g/I! .
酵母エキス5g/l、KH2PO41,5g/I!。Yeast extract 5g/l, KH2PO41.5g/I! .
K2HPO40,5g/n、Mg SO+・7H200
,5g#、ビオチン100g/L尿素3 g/I!。K2HPO40,5g/n, MgSO+・7H200
, 5g#, biotin 100g/L urea 3g/I! .
p H7,2の組成の種培地20亀1を含む25 Qm
l容の三角フラスコで24時間、振盪培養した。得られ
た種培養液1+++lを2 Qmlの下記発酵培地を含
む25 Qml容の三角フラスコに植菌し、30℃。Seed medium with a composition of pH 7.2 containing 20 ml of 25 Qm
The cells were cultured with shaking in a 1-volume Erlenmeyer flask for 24 hours. 1+++l of the obtained seed culture solution was inoculated into a 25 Qml Erlenmeyer flask containing 2 Qml of the following fermentation medium, and incubated at 30°C.
24時間振盪培養を行った。その時のし一グルタミン酸
生産量は28.1g/j!であった。対照として親株Δ
TCC−13032を用いて同様に培養した結果、L−
グルタミン酸の生産量は24.4 g/7!であった。Shaking culture was performed for 24 hours. The production amount of monoglutamic acid at that time was 28.1g/j! Met. Parent strain Δ as control
As a result of culturing in the same manner using TCC-13032, L-
The production amount of glutamic acid is 24.4 g/7! Met.
また、グラミシジン耐性株の取得と同様の変異処理によ
り得られた他のエネルギー代謝阻害を示す抗生物質であ
るオリゴマイシン。Additionally, the acquisition of gramicidin-resistant strains and oligomycin, an antibiotic that exhibits other energy metabolism inhibition, were obtained through similar mutational treatments.
アンチマイシンA、ルタマイシン9パリノマイシン、グ
ラミシジンSのそれぞれの耐性株M−3482゜M−3
488,M−3490,M−3497,M−3499に
ついても、同様に培養を行い、L−グルタミン酸の生産
量を測定した。その結果を第1表に示す。Antimycin A, lutamycin 9 palinomycin, and gramicidin S resistant strains M-3482゜M-3
488, M-3490, M-3497, and M-3499 were similarly cultured, and the amount of L-glutamic acid produced was measured. The results are shown in Table 1.
発酵培地の組成:
糖蜜(糖換算)50g/ffi、NH4H,PO41g
/ R,(N H+)zHP 04 1 g / j
! 、 (N H4)2 S 042 g / i’
、尿素5 g/l、 Mn 504−4H2010vg
/ 1!、 Ca CO330g/ j!、ペニシリ
ンG5 un+ts7ml (p H6,5)第
1 表
::l’J Jt−抗生物質耐性(濃度) L−グル
タ’、l−131!!2 オリゴマイシン (0,1
mg/ml)’、i−FL3g アンチマイシンA
(0,1mg/ff+l)X: −3490ルクマイシ
ン (0,1zg/if)M−3197バリノマイ/
ン (0,1mg/ml)M−3499グラミンジンS
(10xr/m1)1(−7110グラミシジン
(10埒/ml)、へ T CC−13032
実施例2゜
ミン酸軸/2)
26.3
25.4
25.2
25.3
26.6
24.3
種菌として、コリネバクテリウム・グルタミクムH−7
110(FERM BP−1376)株を用いた。実
施例1と同様の種培地にH−7110株を培養して得ら
れた種培養液39m1を、下記組成の発酵培地80 Q
mlを含む22ジャーファーメンタ−に殖菌し、通気i
l VVIII、 1拌数800rpm。Composition of fermentation medium: Molasses (sugar equivalent) 50g/ffi, NH4H, PO41g
/ R, (NH+)zHP 04 1 g / j
! , (NH4)2 S 042 g/i'
, urea 5 g/l, Mn 504-4H2010vg
/ 1! , Ca CO330g/j! , penicillin G5 un+ts 7ml (pH 6,5)
1 Table: :l'J Jt-Antibiotic Resistance (Concentration) L-Gluta', l-131! ! 2 Oligomycin (0,1
mg/ml)', i-FL3g antimycin A
(0,1mg/ff+l)X: -3490 Lucumycin (0,1zg/if)M-3197 Valinomycin
(0.1mg/ml) M-3499 Gramingin S
(10xr/ml) 1 (-7110 gramicidin (10 ml/ml), T CC-13032 Example 2 mic acid axis/2) 26.3 25.4 25.2 25.3 26.6 24.3 As an inoculum, Corynebacterium glutamicum H-7
110 (FERM BP-1376) strain was used. 39 ml of the seed culture solution obtained by culturing the H-7110 strain in the same seed medium as in Example 1 was added to the fermentation medium 80Q with the following composition.
Incubate the bacteria in a 22-jar fermentor containing ml and aerate.
l VVIII, 1 stirring number 800 rpm.
p H7,6(アンモニア水により調整)で培養を行っ
た。Culture was performed at pH 7.6 (adjusted with aqueous ammonia).
培地中の糖が消費され、p Hが上昇時に、ペリ/リン
Gを5units/mlになるように添加後、40%の
砧を含む加水糖蜜を連続的に添加しながら、43時間の
培養を行った。対照として、親株、へTCC−1303
2株を用いて、同様に培養を行った。H−7]10株及
びATCC−13032株でのグルタミン酸i4:産1
を第2表に示す。When the sugar in the medium was consumed and the pH rose, Peri/Lin G was added to 5 units/ml, and then cultured for 43 hours while continuously adding hydrated molasses containing 40% minuta. went. As a control, the parent strain, TCC-1303
Culture was performed in the same manner using two strains. H-7] Glutamic acid i4: production 1 in 10 strains and ATCC-13032 strain
are shown in Table 2.
発酵培地の組成: 糖蜜(iFi換算)30g/l、NH,H2PO。Composition of fermentation medium: Molasses (iFi equivalent) 30g/l, NH, H2PO.
1.21?/L (NH9)zHP○、 1.2g
/i’。1.21? /L (NH9)zHP○, 1.2g
/i'.
Mn5O,・4〜6H20100g/l。Mn5O, 4~6H20100g/l.
Cu SO= ・5H2020g/ 1 (pH7,6
)第
表
菌
株
L−グルタミン酸軸/β)
対糖収率(%)
ΔT CC−13032
発明の効果
本発明により、
収率よくL−グルタミン酸を得
ることかできる。Cu SO= ・5H2020g/1 (pH7,6
) Table 1 Bacterial Strain L-Glutamic Acid Axis/β) Sugar Yield (%) ΔT CC-13032 Effects of the Invention According to the present invention, L-glutamic acid can be obtained in good yield.
Claims (1)
し、グラミシジンに耐性を有し、L−グルタミン酸生産
能を有する微生物を培地に培養し、培養物中にL−グル
タミン酸を生成蓄積せしめ、これを採取することを特徴
とする発酵法によるL−グルタミン酸の製造法。Cultivating a microorganism belonging to the genus Corynebacterium or Brevibacterium, resistant to gramicidin, and capable of producing L-glutamic acid in a medium, producing and accumulating L-glutamic acid in the culture, and collecting the same. A method for producing L-glutamic acid by a fermentation method, characterized by:
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15975088A JPH029384A (en) | 1988-06-28 | 1988-06-28 | Production of l-glutamic acid by fermentation process |
CN 89106345 CN1039442A (en) | 1988-06-28 | 1989-06-28 | Produce the method for L-L-glutamic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15975088A JPH029384A (en) | 1988-06-28 | 1988-06-28 | Production of l-glutamic acid by fermentation process |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH029384A true JPH029384A (en) | 1990-01-12 |
Family
ID=15700444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15975088A Pending JPH029384A (en) | 1988-06-28 | 1988-06-28 | Production of l-glutamic acid by fermentation process |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPH029384A (en) |
CN (1) | CN1039442A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1035727C (en) * | 1991-04-02 | 1997-08-27 | 黄文涛 | Fermentation technology of L-glutamic acid |
JP3880636B2 (en) * | 1994-01-10 | 2007-02-14 | 味の素株式会社 | Method for producing L-glutamic acid by fermentation |
DE69535643D1 (en) * | 1994-08-19 | 2007-12-27 | Ajinomoto Kk | Process for the fermentative production of L-lysine and L-glutamic acid |
CN100999756B (en) * | 2006-12-18 | 2010-06-02 | 浙江大学 | Process of preparing gamma-polyglutamic acid by bacillus subtilis and glutamic acid bacillus mixed cultivating system |
-
1988
- 1988-06-28 JP JP15975088A patent/JPH029384A/en active Pending
-
1989
- 1989-06-28 CN CN 89106345 patent/CN1039442A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1039442A (en) | 1990-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH03232497A (en) | Production of l-glutamine by fermentation | |
JPH044887A (en) | Fermentative production of l-lysine | |
JP2004516833A (en) | Corynebacterium ammoniagenes CJIP009, a microorganism that produces 5'-inosinic acid in high yield, and method for producing 5'-inosinic acid using the same | |
JPS6257315B2 (en) | ||
US5650304A (en) | Process for producing L-lysine by fermentation | |
JPH08322583A (en) | Production of l-isoleucine by fermentation method | |
JPH06133787A (en) | Production of l-isoleucine by fermentation | |
IE69844B1 (en) | Microbiological process for the preparation of 6-hydroxypicolinic acid | |
JPH029384A (en) | Production of l-glutamic acid by fermentation process | |
JP2578463B2 (en) | Production method of L-lysine by fermentation method | |
JP2578474B2 (en) | Method for producing L-glutamic acid | |
CA1215338A (en) | Process for producing l-glutamic acid by fermentation | |
JPH057493A (en) | Production of l-valine by fermentation | |
JPS63248392A (en) | Production of l-leucine by fermentation | |
JPS59113894A (en) | Preparation of l-glutamic acid by fermentation | |
JPS61119194A (en) | Production of l-ornithine through fermentation process | |
KR0146493B1 (en) | Process for producing l-alanine by fermentation | |
HU215248B (en) | Process for producing l-lysine | |
JPH055476B2 (en) | ||
JPS5811198B2 (en) | Hatsukouhou Niyoru Urokanin Sanno Seizouhou | |
JPS61139398A (en) | Production of l-glutamic acid | |
JPS59154994A (en) | Preparation of amino acid by fermentation | |
JPH0692A (en) | Production of l-arginine by fermentation method | |
JPS5988094A (en) | Production of l-lysine by fermentation | |
JPH045437B2 (en) |